Company Filing History:
Years Active: 2002-2004
Title: Aspandiar G Katki: Innovator in Nucleoside Applications
Introduction
Aspandiar G Katki is a prominent inventor based in Gaithersburg, MD (US). She has made significant contributions to the field of medical imaging and treatment through her innovative work on nucleosides. With a total of 7 patents, her research focuses on methods for diagnosing and treating tumors.
Latest Patents
Her latest patents include groundbreaking methods for diagnosing and treating tumors by administering nucleoside analogues. These analogues are activated by thymidylate synthase and/or thymidine kinase enzymes, converting them into diagnostic or toxic metabolites. Additionally, her work involves uridine analogue compounds and their compositions, which include pharmaceutically acceptable carriers. For diagnostic applications, she describes compounds containing a label and methods for their use.
Career Highlights
Aspandiar G Katki is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. Her role at this esteemed institution allows her to contribute to vital research that has the potential to impact cancer treatment and diagnostics significantly.
Collaborations
Some of her notable coworkers include Raymond W Klecker, Jr. and Jerry M Collins. Their collaborative efforts enhance the research environment and foster innovation in their respective fields.
Conclusion
Aspandiar G Katki's work exemplifies the intersection of innovation and healthcare, particularly in the realm of nucleoside applications for tumor diagnosis and treatment. Her contributions continue to pave the way for advancements in medical science.